These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 28707541

  • 21. The evidence on effectiveness of weekly vs triweekly cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC): a systematic review and meta-analysis.
    Jacinto JK, Co J, Mejia MB, Regala EE.
    Br J Radiol; 2017 Nov; 90(1079):20170442. PubMed ID: 29053029
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
    Fields AL, Anderson PS, Goldberg GL, Wadler S, Beitler J, Sood B, Runowicz CD.
    Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
    [Abstract] [Full Text] [Related]

  • 24. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY, Li LY, Shu KY, Pan M, Li HP, Luo B.
    Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
    [Abstract] [Full Text] [Related]

  • 25. Outcomes and toxicities for the treatment of stage IVB cervical cancer.
    Hwang JH, Lim MC, Seo SS, Kang S, Park SY, Kim JY.
    Arch Gynecol Obstet; 2012 Jun; 285(6):1685-93. PubMed ID: 22173823
    [Abstract] [Full Text] [Related]

  • 26. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
    Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Lin WC, Yang SN, Lin FJ.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1370-7. PubMed ID: 16979836
    [Abstract] [Full Text] [Related]

  • 27. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB, Cho JH, Keum KC, Lee CG, Seong J, Suh CO, Kim GE.
    Gynecol Oncol; 2007 Jan 01; 104(1):58-63. PubMed ID: 16919718
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers.
    Chen F, Luo H, Xing L, Liang N, Xie J, Zhang J.
    Thorac Cancer; 2018 Jan 01; 9(1):59-65. PubMed ID: 29024498
    [Abstract] [Full Text] [Related]

  • 32. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Tsukuda M, Ishitoya J, Matsuda H, Horiuchi C, Taguchi T, Takahashi M, Nishimura G, Kawakami M, Watanabe M, Niho T, Kawano T, Ikeda Y, Sakuma Y, Shiono O, Komatsu M.
    Cancer Chemother Pharmacol; 2010 Sep 01; 66(4):729-36. PubMed ID: 20033810
    [Abstract] [Full Text] [Related]

  • 33. Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer: A Meta-Analysis.
    Chen X, Zou H, Li H, Lin R, Su M, Zhang W, Zhou Y, Zhang P, Hou M, Deng X, Zou C.
    Int J Gynecol Cancer; 2017 Feb 01; 27(2):344-349. PubMed ID: 27984377
    [Abstract] [Full Text] [Related]

  • 34. HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.
    Wang CC, Lai CH, Huang YT, Chao A, Chou HH, Hong JH.
    Int J Radiat Oncol Biol Phys; 2012 Nov 15; 84(4):e499-506. PubMed ID: 22889667
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
    Toita T, Kitagawa R, Hamano T, Umayahara K, Hirashima Y, Aoki Y, Oguchi M, Mikami M, Takizawa K, Cervical Cancer (Vulva Cancer) Committee of Japanese Gynecologic Oncology Group (JGOG).
    Gynecol Oncol; 2012 Aug 15; 126(2):211-6. PubMed ID: 22555110
    [Abstract] [Full Text] [Related]

  • 40. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
    Kato S, Ohno T, Thephamongkhol K, Chansilpa Y, Yuxing Y, Devi CR, Bustam AZ, Calaguas MJ, de los Reyes RH, Cho CK, Dung TA, Supriana N, Mizuno H, Nakano T, Tsujii H.
    Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):751-7. PubMed ID: 19836154
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.